RxDoctor Payments Data

David Adams, PA

Physician Assistant · Prestonsburg, KYNPI 1366094195

Payments from drug & device makers

$3,041in general payments, 2019–2025

Across 182 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$682
  • Bayer$288
  • AbbVie$214
  • Lilly USA, LLC$214
  • Boehringer Ingelheim$195
  • Takeda Pharmaceuticals U.S.A., Inc.$177
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$3,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,041 in reported general payments places this provider in the 85th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$26,831
Medicare patients
165
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide63$67,183
EliquisApixaban77$55,221
JardianceEmpagliflozin73$50,479
OzempicSemaglutide50$49,540
LinzessLinaclotide46$30,730
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$23,716
JanuviaSitagliptin Phosphate25$22,934
FarxigaDapagliflozin Propanediol23$21,919
KerendiaFinerenone20$13,156
Combivent RespimatIpratropium/Albuterol Sulfate27$12,981
TrulancePlecanatide17$12,374
MyrbetriqMirabegron19$11,334
TradjentaLinagliptin16$9,308
SymbicortBudesonide/Formoterol Fumarate32$8,816
VeozahFezolinetant13$7,128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$195$72,768116 claims
Lilly USA, LLCMounjaro$214$67,18363 claims
PfizerEliquis$70$55,22177 claims
Novo NordiskOzempic, Levemir$168$52,18666 claims
AstraZenecaFarxiga, Symbicort$82$30,73555 claims
AbbVieLinzess$214$30,73046 claims
GSKTrelegy Ellipta, Incruse Ellipta$38$28,49845 claims
BayerKerendia$288$13,15620 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$60$12,37417 claims
NovartisEntresto$682$6,73513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Prestonsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →